Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias

被引:64
作者
Pereira, RMR [1 ]
Velloso, ERP [1 ]
Menezes, Y [1 ]
Gualandro, S [1 ]
Vassalo, J [1 ]
Yoshinari, NH [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Sch Med, Div Rheumatol, BR-02146903 Sao Paulo, Brazil
关键词
bone marrow; cytopenia; systemic lupus erythematosus;
D O I
10.1007/BF01451051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied 21 bone marrow specimens from 21 patients with systemic lupus erythematosus (SLE) and peripheral cytopenias: anaemia (Hb <10 g/dl), and/or leucopenia (white blood cell count <4 x 10(9)/l), and/or thrombocytopenia (platelets < 150 x 10(9)/l). None of the patients had used immunosuppressive drugs in the 2 months before the study, and 11 (52.4%) had never used these drugs. The global and specific series cellularity, degree of fibrosis and necrosis were evaluated by bone marrow trephine; morphological abnormalities and iron stores were evaluated by cytological smears. The most important abnormalities viewed in bone marrow biopsies were: global hypocellularity (47.6%), increased reticulin proliferation (76.2%) with myelofibrosis in one patient, and necrosis (19.0%). The marrow aspirates were difficult to obtain in four patients, who showed an increased reticulin proliferation on histological analysis. Plasmocytosis was present in 26.7% of cases and in one there was a serum monoclonal component (IgG kappa). Iron stores were normal or increased in 26.7% of specimens and decreased or absent in 73.3%. The most frequent peripheral abnormality was leucopenia in 90.4% (19/21) and granulocytic hypoplasia was observed in 47.3% (9/19) of these patients. We conclude that the bone marrow may be a target organ in SLE with cytopenias.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 24 条
[1]   PLASMAPHERESIS IN ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECTS ON CLINICAL, SERUM, AND CELLULAR ABNORMALITIES - CASE-REPORT [J].
ABDOU, NI ;
LINDSLEY, HB ;
POLLOCK, A ;
STECHSCHULTE, DJ ;
WOOD, G .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 19 (01) :44-54
[2]  
BAILEY FA, 1989, ARTHRITIS RHEUM, V32, P901
[3]   LUPUS ANTICOAGULANT IN MYELOFIBROSIS [J].
BERNHARDT, B ;
VALLETTA, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1976, 272 (02) :229-231
[4]  
BORBA EF, 1993, ACTA HAEMATOL-BASEL, V89, P82
[5]   SERUM INHIBITOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS ASSOCIATED WITH APLASTIC-ANEMIA [J].
BROOKS, BJ ;
BROXMEYER, HE ;
BRYAN, CF ;
LEECH, SH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (07) :1474-1477
[6]   HEMATOLOGIC ASPECTS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - CURRENT CONCEPTS [J].
BUDMAN, DR ;
STEINBERG, AD .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (02) :220-229
[7]  
BURKHARDT R, 1965, Semin Hematol, V2, P29
[8]   IDIOPATHIC MYELOFIBROSIS - A POSSIBLE ROLE FOR IMMUNE-COMPLEXES IN THE PATHOGENESIS OF BONE-MARROW FIBROSIS [J].
CAPPIO, FC ;
VIGLIANI, R ;
NOVARINO, A ;
CAMUSSI, G ;
CAMPANA, D ;
GAVOSTO, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 49 (01) :17-21
[9]   MYELOFIBROSIS AS A CAUSE OF PANCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
DALY, HM ;
SCOTT, GL .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (11) :1219-1222
[10]   SERUM INHIBITORS OF HEMATOPOIESIS IN A PATIENT WITH APLASTIC-ANEMIA AND SYSTEMIC LUPUS-ERYTHEMATOSUS - RECOVERY AFTER EXCHANGE PLASMAPHERESIS [J].
FITCHEN, JJ ;
CLINE, MJ ;
SAXON, A ;
GOLDE, DW .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (03) :537-542